American Renal Associates (ARA) Prices 7.5M Common Stock IPO at $22/Share

American Renal Associates Holdings, Inc. (NYSE: ARA) announced the pricing of its initial public offering of 7,500,000 shares of common stock at an initial public offering price of $22.00 per share. ARA has granted the underwriters for the offering a 30-day option to purchase up to an additional 1,125,000 shares of common stock at the initial public offering price. ARA’s common stock is expected to begin trading on the New York Stock Exchange under the ticker symbol “ARA” on April 21, 2016. The offering is expected to close on April 26, 2016, subject to customary closing conditions.

*** The Company was previously expecting a range of $20 to $23 per share.

BofA Merrill Lynch, Barclays and Goldman, Sachs & Co. are serving as lead joint book-running managers and as representatives of the underwriters for the offering. Wells Fargo Securities, LLC and SunTrust Robinson Humphrey are acting as joint book-running managers. Leerink Partners is acting as co-manager.

A registration statement relating to these securities has been declared effective by the U.S. Securities and Exchange Commission on April 20, 2016. The offering is being made only by means of a prospectus. A copy of the final prospectus related to the offering may be obtained, when available, from: BofA Merrill Lynch, 222 Broadway, New York, NY 10038, Attn: Prospectus Department, email: [email protected], Barclays Capital Inc., c/o Broadridge Financial Solutions, Attn: Prospectus Department, 1155 Long Island Avenue, Edgewood, NY 11717, email: [email protected] or Goldman, Sachs & Co., Attn: Prospectus Department, 200 West Street, New York, NY 10282, email: [email protected].

You May Also Be Interested In

• Fisker (FSR) files form 10-K, sees more job cuts, reiterates going concern doubts
• Renasant Corp. (RNST) Appoints Kevin D. Chapman as Next CEO
• LuxUrban Hotels (LUXH) Files $50M Mixed Shelf